康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09966 康宁杰瑞制药-B

已收盘 03-24 16:08:20

8.160

+0.120

+1.49%

最高8.360	最低7.880	成交量111.30万
今开8.360	昨收8.040	日振幅5.97%
总市值79.07亿	流通市值79.07亿	总股本9.69亿
成交额895.70万	换手率0.11%	流通股本9.69亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":8.16,"timestamp":1774339700008,"preClose":8.04,"halted":0,"volume":1113000,"delay":0,"changeRate":0.014925373134328483,"floatShares":969000000,"shares":969000000,"eps":0.17,"marketStatus":"已收盘","change":0.12,"latestTime":"03-24 16:08:20","open":8.36,"high":8.36,"low":7.88,"amount":8956964,"amplitude":0.059701,"askPrice":8.16,"askSize":2000,"bidPrice":8.05,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.258911,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":8.04,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":0.984136,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966","defaultTab":"news","newsList":[{"id":"2621337490","title":"康宁杰瑞制药-B(09966)：KN026辅助治疗HER2+乳腺癌III期临床研究完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2621337490","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621337490?lang=zh_cn&edition=full","pubTime":"2026-03-24 08:07","pubTimestamp":1774310843,"startTime":"0","endTime":"0","summary":"双靶向联合化疗辅助治疗HER2+ BC 对比仅含曲妥珠单抗的方案，可进一步降低复发风险，其中淋巴结阳性人群的获益最为显著。KN026-007是一项随机、对照、开放、多中心III期临床研究，预计纳入约1,800例术后组织学确认区域淋巴结阳性数量≥4个的可切除HER2+ BC患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","III","09966","BK4134"],"gpt_icon":0},{"id":"2620270254","title":"康宁杰瑞制药-B(09966.HK)：JSKN016用于治疗TNBC的III期临床研究完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2620270254","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620270254?lang=zh_cn&edition=full","pubTime":"2026-03-20 08:17","pubTimestamp":1773965823,"startTime":"0","endTime":"0","summary":"格隆汇3月20日丨康宁杰瑞制药-B发布公告，JSKN016用于治疗三阴性乳腺癌的一项III期临床研究已成功完成首例患者给药。TNBC约占所有BC病例的15%至20%。　　JSKN016-301是一项开放、随机、对照、多中心III期临床研究，预计将在中国约60家临床研究中心开展。该研究计划入组经至少二线系统性治疗失败的不可手术切除的局部晚期、复发或转移性TNBC患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260320/32083524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["III","BK1161","BK4134","BK1574","09966"],"gpt_icon":0},{"id":"2620123279","title":"康宁杰瑞制药-B(09966)委任王飞为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2620123279","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620123279?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:52","pubTimestamp":1773831136,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，委任王飞先生为本公司首席财务官，自2026年3月16日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2619246368","title":"康宁杰瑞制药-B(09966)：JSKN027的I期临床研究完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2619246368","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619246368?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:39","pubTimestamp":1773664765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B 发布公告，公司自主研发的程序性死亡配体1╱ 血管内皮生长因子受体2双特异性抗体偶联药物JSKN027治疗晚期恶性实体瘤的I期临床研究已成功完成首例患者给药。JSKN027是公司第五款进入临床研究阶段的ADC，也是全球首款进入临床研究阶段的PD-L1/VEGFR2双抗ADC。基于其细胞毒杀伤、抗血管生成及免疫调节等多重作用机制，JSKN027有望为多种实体瘤治疗提供新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2619830157","title":"康宁杰瑞制药-B(09966)：JSKN021的IND申请获CDE正式受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2619830157","media":"智通财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619830157?lang=zh_cn&edition=full","pubTime":"2026-03-13 08:04","pubTimestamp":1773360243,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B(09966)发布公告，公司自主研发的靶向表皮生长因子受体(EGFR)╱人表皮生长因子受体3(HER3)的双抗双载荷偶联药物(ADC(s))JSKN021新药临床试验(IND)申请，已获国家药监局药品审评中心(CDE)正式受理。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_33.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_33.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1223082196.USD","CDE","BK4017","BK1161","IND","LU1223083913.SGD","09966","BK1574","LU1223082519.USD"],"gpt_icon":0},{"id":"2619150947","title":"每日卖空追踪 | 康宁杰瑞制药-B 03月12日卖空量成交3.7万股，卖空比例为2.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619150947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619150947?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304244,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间03月12日，跌4.26%，卖空量成交3.7万股，较上一交易日减少60.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163637a46376f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163637a46376f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2619965150","title":"王宏伟空降CTO，康宁杰瑞的产业化拐点来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2619965150","media":"读商时代","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619965150?lang=zh_cn&edition=full","pubTime":"2026-03-12 15:46","pubTimestamp":1773301580,"startTime":"0","endTime":"0","summary":"王宏伟的加入，正好补上了康宁杰瑞最核心的短板——产业化能力。而王宏伟此前在ADC生产工艺优化和制造体系建设方面的经验，正是康宁杰瑞当前最需要的能力。换句话说，康宁杰瑞此时引入王宏伟，并不是为了加强研发，而是为了打通创新药商业化的“最后一公里”。对康宁杰瑞来说，王宏伟的到来更像是一块“产业化拼图”的补齐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031215535697af1077&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031215535697af1077&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2618883922","title":"礼来宣布未来十年投资30亿美元扩展在华供应链产能；恒瑞前高管王宏伟加入康宁杰瑞任首席技术官｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2618883922","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618883922?lang=zh_cn&edition=full","pubTime":"2026-03-12 01:00","pubTimestamp":1773248442,"startTime":"0","endTime":"0","summary":"｜2026年3月12日星期四｜NO.1恒瑞前高管王宏伟加入康宁杰瑞生物制药，任首席技术官3月11日，康宁杰瑞生物制药发布自愿公告，正式宣布委任王宏伟博士为公司首席技术官，全面负责工艺开发、分析开发、生产和质量相关工作。王宏伟的职业生涯起步于恒瑞医药，于2011年7月至2018年7月任恒瑞医药高级研究员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603123669204642.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"6afbb4a2a5e710528ea777914b8996d7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603123669204642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0882574055.USD","LU2473716301.USD","IE00BFMHRM44.USD","LU1551013425.SGD","LU2272731782.SGD","LU1814569148.SGD","LU0198837287.USD","LU0640476718.USD","LU1366192091.USD","LU2213496289.HKD","SGXZ57979304.SGD","LU2324357040.USD","LU2357305700.SGD","IE00BK4W5L77.USD","LU0210536198.USD","LU0203202063.USD","LU2360106947.USD","LU0106261372.USD","LU2361045086.USD","LU1720051108.HKD","BK1574","LU2028103732.USD","LU2896262040.SGD","LU2322448791.USD","IE0004445015.USD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","LU0672654240.SGD","LU0689472784.USD","IE00BKPKM429.USD","LU1061106388.HKD","LLII","SG9999017495.SGD","LU0320765059.SGD","IE00BFSS7M15.SGD","LU0823434583.USD","LU1267930730.SGD","LU1720051017.SGD","SG9999001176.USD","LU2461242641.AUD","SGXZ51526630.SGD","LU1280957306.USD","LU1064131342.USD","LU2023251221.USD","SG9999015945.SGD","LU2471134879.HKD","IE0004445239.USD","LU2756315318.SGD","LU2237443549.SGD","LU0683600562.USD","LU1868836757.USD","LU2168564149.EUR","LU2023250504.SGD","IE00BFSS8Q28.SGD","LU2168564222.USD","LU2168563687.JPY","LU1232071149.USD","LU2112291526.USD","LU2237443465.HKD","LU1093756325.SGD","SG9999018857.SGD","LU2552382058.USD","LU0158827948.USD","LU2552382132.HKD","LU1623119135.USD","LU2089283258.USD","LU2491050071.SGD","SG9999018865.SGD","LU0109394709.USD","SGXZ81514606.USD","LU2602419157.SGD","LU2471134796.USD","LU2552382215.SGD","LU2089284900.SGD","LU0114720955.EUR","LU0820561818.USD","BK4516","BK4581","IE00BK4W5M84.HKD","IE00B4JS1V06.HKD","LU0708995401.HKD","ELIL","LU1323610961.USD","LU0354030511.USD","LU2746668974.SGD","LLYZ","IE00B7KXQ091.USD","LU1988902786.USD","LU1974910355.USD","SG9999013999.USD","LU1629891620.HKD","SG9999015952.SGD","IE00B1XK9C88.USD","LU2089984988.USD","LU0456855351.SGD","LU0203201768.USD","LU2106854487.HKD","LU0820562030.AUD","LU2023250330.USD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU0225283273.USD","LU0006306889.USD","IE0001KFT4U8.USD","LU0471298694.HKD","LU0353189680.USD","LU0787776722.HKD","LU0385154629.USD","LU0823434740.USD","SG9999014906.USD","LU2471134523.USD","LU2236285917.USD","BK4148","IE00B775H168.HKD","LU0256863902.USD","LU2265009873.SGD","LU2087625088.SGD","LU0417517546.SGD","LU1992135399.USD","09966","BK4588","LU1917777945.USD","LU0786609619.USD","LU1023059063.AUD","BK1161","LU0058720904.USD","LU2456880835.USD","LU2491050154.USD","LU0266013472.USD","IE00BKDWB100.SGD","LU2272731600.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU1712237335.SGD","LU0889565916.HKD","LU1069344957.HKD","LU2272731865.HKD","SG9999014880.SGD","LU0256863811.USD","BK4512","LU0096364046.USD","LU0158827781.USD","IE0005OL40V9.USD","IE0009355771.USD","LU0823416689.USD","LU0353189763.USD","BK4534","LU2491049909.HKD","LU2361044949.HKD","LU2108987350.USD","LU1868836591.USD","SG9999015978.USD","LU0109391861.USD","LU1127390331.HKD","LU0348723411.USD","LLYX","LU1868837300.USD","ELIS","LU0354030438.USD","SG9999001176.SGD","LU2237438978.USD","IE00BJJMRY28.SGD","LU1868837136.USD","LU2168564065.EUR","SG9999014914.USD","688321","LU2746668461.USD","LU0466842654.USD","LU0094547139.USD","LU2237443978.SGD","LU0964807845.USD","BK4599","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU2322448957.HKD","LU0079474960.USD","IE00BWXC8680.SGD","IE0002141913.USD","IE00B2B36J28.USD","GB00BDT5M118.USD","LU0943347566.SGD","LU1093756168.USD","BK1515","IE00BJLML261.HKD","LU1551013342.USD","LU0882574139.USD","LU0471298777.SGD","LU0316494557.USD","BK4007","IE00BN29S564.USD","LU0323591593.USD","LU2756315664.SGD","SG9999014898.SGD","LU2417539215.USD","LU2237443622.USD","LU1057294990.SGD","LU1548497426.USD","SGXZ31699556.SGD","LU1992135472.HKD","LU0097036916.USD","LU0320765992.SGD","LU2462157665.USD","LU1804176565.USD","LU1983299246.USD","LU0289739699.SGD","LU2168564495.EUR","LU2063271972.USD","LU2271345857.HKD","SGXZ99366536.SGD","LU0238689110.USD","LU0122379950.USD","LU1868836914.USD","SG9999015986.USD","LU2237443895.HKD","LU2211815571.USD","LU0820561909.HKD","LU0234572021.USD","IE00BJJMRX11.SGD","BK4533","LU0061475181.USD","LU2237443382.USD","LU2264538146.SGD","LU2750360641.GBP","LU2750360997.AUD","LLY","LU2111349929.HKD","BK4585","LU2361044865.SGD","LU0432979614.USD","LU2468319806.SGD","LU1035775433.USD","LU1145028129.USD"],"gpt_icon":1},{"id":"2618943510","title":"康宁杰瑞制药-B03月11日主力净流入108.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618943510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618943510?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:15","pubTimestamp":1773216929,"startTime":"0","endTime":"0","summary":"03月11日, 康宁杰瑞制药-B股价涨3.24%，报收8.93元，成交金额1180.3万元，换手率0.14%，振幅8.32%，量比1.10。康宁杰瑞制药-B今日主力资金净流入108.9万元，上一交易日主力净流出0万元。该股近5个交易日上涨16.58%，主力资金累计净流出3.4万元；近20日主力资金累计净流出164.4万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161658a6b786ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161658a6b786ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2618998822","title":"康宁杰瑞制药-B(09966)委任王宏伟为公司首席技术官","url":"https://stock-news.laohu8.com/highlight/detail?id=2618998822","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618998822?lang=zh_cn&edition=full","pubTime":"2026-03-11 08:09","pubTimestamp":1773187763,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，委任王宏伟博士为公司首席技术官。王博士将主要负责公司的工艺开发及分析开发、生产和质量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2618845569","title":"康宁杰瑞制药-B盘中异动 急速拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618845569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618845569?lang=zh_cn&edition=full","pubTime":"2026-03-10 09:50","pubTimestamp":1773107413,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时50分，康宁杰瑞制药-B股票出现异动，股价大幅拉升5.37%。截至发稿，该股报8.440港元/股，成交量17.6万股，换手率0.02%，振幅4.24%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康宁杰瑞制药-B股票所在的生物技术行业中，整体涨幅为3.70%。康宁杰瑞制药-B公司简介：康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310095013a6b3d054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310095013a6b3d054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2618667267","title":"每日卖空追踪 | 康宁杰瑞制药-B 03月09日卖空量成交2.1万股，卖空比例为2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618667267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618667267?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045043,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间03月09日，涨2.04%，卖空量成交2.1万股，较上一交易日减少41.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163629a6b1ca14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163629a6b1ca14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2617065459","title":"每日卖空追踪 | 康宁杰瑞制药-B 03月06日卖空量成交1.4万股，卖空比例为1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617065459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617065459?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785842,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间03月06日，涨0.77%，卖空量成交1.4万股，较上一交易日减少46.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163627a4535ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163627a4535ef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2616530988","title":"每日卖空追踪 | 康宁杰瑞制药-B 03月04日卖空量成交7万股，卖空比例为3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616530988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616530988?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613042,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间03月04日，跌3.4%，卖空量成交7万股，较上一交易日减少7.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163627a6a152c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163627a6a152c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2616353069","title":"康宁杰瑞制药-B03月04日遭主力抛售147.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616353069?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612130,"startTime":"0","endTime":"0","summary":"03月04日, 康宁杰瑞制药-B股价跌3.40%，报收7.66元，成交金额1515.8万元，换手率0.20%，振幅5.55%，量比1.31。康宁杰瑞制药-B今日主力资金净流出147.6万元，上一交易日主力净流出99.2万元。该股近5个交易日下跌15.17%，主力资金累计净流出15.4万元；近20日主力资金累计净流出263.9万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161659a6a13b5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161659a6a13b5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2616361530","title":"每日卖空追踪 | 康宁杰瑞制药-B 03月02日卖空量成交4.4万股，卖空比例为2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616361530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616361530?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440245,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间03月02日，跌7.58%，卖空量成交4.4万股，较上一交易日减少84.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163711a441549a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163711a441549a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2616361376","title":"康宁杰瑞制药-B盘中异动 股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616361376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616361376?lang=zh_cn&edition=full","pubTime":"2026-03-02 09:32","pubTimestamp":1772415148,"startTime":"0","endTime":"0","summary":"2026年03月02日早盘09时32分，康宁杰瑞制药-B股票出现异动，股价急速跳水5.40%。康宁杰瑞制药-B股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，正大企业国际、荃信生物-B、愉悦集团涨幅较大，振幅较大的相关个股有康诺亚-B、MIRXES-B、康宁杰瑞制药-B，振幅分别为6.52%、4.89%、4.71%。康宁杰瑞制药-B公司简介：康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302093228a72f3a62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302093228a72f3a62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2614015891","title":"每日卖空追踪 | 康宁杰瑞制药-B 02月27日卖空量成交12万股，卖空比例为6.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614015891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614015891?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181044,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间02月27日，涨4.94%，卖空量成交12万股，较上一交易日减少47.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163636a725f65f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163636a725f65f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2614910188","title":"康宁杰瑞制药-B02月27日获主力加仓111.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614910188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614910188?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:15","pubTimestamp":1772180137,"startTime":"0","endTime":"0","summary":"02月27日, 康宁杰瑞制药-B股价涨4.94%，报收8.71元，成交金额1860.7万元，换手率0.22%，振幅4.94%，量比2.79。康宁杰瑞制药-B今日主力资金净流入111.7万元，上一交易日主力净流入113.7万元。该股近5个交易日下跌1.63%，主力资金累计净流入264.8万元；近20日主力资金累计净流出210.0万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161751a725e0a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161751a725e0a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2614073558","title":"康宁杰瑞制药-B盘中异动 股价大跌5.06%报8.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614073558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614073558?lang=zh_cn&edition=full","pubTime":"2026-02-26 14:22","pubTimestamp":1772086928,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘14时22分，康宁杰瑞制药-B股票出现波动，股价急速下跌5.06%。截至发稿，该股报8.450港元/股，成交量74.8万股，换手率0.08%，振幅5.17%。资金方面，该股资金流入129.159万港元，流出495.485万港元。康宁杰瑞制药-B股票所在的生物技术行业中，整体跌幅为4.21%。康宁杰瑞制药-B公司简介：康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022614220895420ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022614220895420ea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":-0.0864},{"period":"1month","weight":-0.1261},{"period":"3month","weight":-0.2847},{"period":"6month","weight":-0.3777},{"period":"1year","weight":0.0865},{"period":"ytd","weight":-0.1796}],"compareEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.0769},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.0806},{"period":"1year","weight":0.0292},{"period":"ytd","weight":-0.0487}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。该公司高度差异化的内部管线由处于不同研发阶段的ADCs、单克隆抗体及双特异性抗体肿瘤药物组成。该公司的候选药物包括KN046（PD-L1/CTLA-4双特异性抗体）, KN026（抗HER2双特异性抗体）, KN035（皮下注射PD-L1）, JSKN003（HER2双表位ADC）等，用于1L sq NSCLC、乳腺癌 2+HER L1、晚期实体瘤、HER2表达实体瘤等适应症。","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.117313},{"month":2,"riseRate":0.571429,"avgChangeRate":0.192959},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.035536},{"month":4,"riseRate":0.833333,"avgChangeRate":0.061128},{"month":5,"riseRate":0.5,"avgChangeRate":-0.016858},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.029877},{"month":7,"riseRate":0.333333,"avgChangeRate":0.059359},{"month":8,"riseRate":0.333333,"avgChangeRate":0.022561},{"month":9,"riseRate":0.333333,"avgChangeRate":0.158319},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.030396},{"month":11,"riseRate":0.5,"avgChangeRate":0.042537},{"month":12,"riseRate":0.5,"avgChangeRate":-0.017716}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}